Regulatory News
Friday, December 30, 2016
BRIEF-Incyte announces first patient treated in clinical trial program in graft-versus-host disease
* Incyte announces first patient treated in pivotal clinical
trial program for ruxolitinib (Jakafi) in graft-versus-host
disease
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment